Coya is currently conducting the ALSTARS Trial, a Phase 2, randomized, multi-center, double-blind, placebo-controlled study to evaluate the efficacy and safety of COYA 302 for the treatment of ALS ( ...

NEW YORK CITY, NY / ACCESS Newswire / June 10, 2026 / Emerging Growth Research today announced the release of its Initiation ...

The three partners are proud to jointly serve as Platinum Sponsors of the 2026 BDSRA Annual Family Conference, where they will provide an update on the Batten-1 program and the ...